Archives
- 2018-07
- 2019-04
- 2019-05
- 2019-06
- 2019-07
- 2019-08
- 2019-09
- 2019-10
- 2019-11
- 2019-12
- 2020-01
- 2020-02
- 2020-03
- 2020-04
- 2020-05
- 2020-06
- 2020-07
- 2020-08
- 2020-09
- 2020-10
- 2020-11
- 2020-12
- 2021-01
- 2021-02
- 2021-03
- 2021-04
- 2021-05
- 2021-06
- 2021-07
- 2021-08
- 2021-09
- 2021-10
- 2021-11
- 2021-12
- 2022-01
- 2022-02
- 2022-03
- 2022-04
- 2022-05
- 2022-06
- 2022-07
- 2022-08
- 2022-09
- 2022-10
- 2022-11
- 2022-12
- 2023-01
- 2023-02
- 2023-03
- 2023-04
- 2023-05
- 2023-06
- 2023-07
- 2023-08
- 2023-09
- 2023-10
- 2023-11
- 2023-12
- 2024-01
- 2024-02
- 2024-03
- 2024-04
- 2024-05
- 2024-06
- 2024-07
- 2024-08
- 2024-09
- 2024-10
- 2024-11
- 2024-12
- 2025-01
- 2025-02
- 2025-03
-
Bisphosphonates significantly reduce or prevent SREs The
2019-06-20
Bisphosphonates significantly reduce or prevent SREs. The use of Zol for patients with bone metastases is currently the gold standard treatment [4]. However, it is still unclear whether Zol contributes to a survival benefit [9]. Niikura et al. recently reported that Zol did not prolong progression-f
-
Respecto a la ideolog a que ostent en
2019-06-20
Respecto 8-Hydroxy-DPAT hydrobromide Supplier la ideología que ostentó en los años ochenta, temporalidad en que fue ajusticiado el coronel Máximo Zepeda, podemos decir que ésta se fue matizando durante su larga trayectoria periodística hasta su decadencia financiera y posterior desaparición, la que
-
br Conflict of interest br Acknowledgments
2019-06-20
Conflict of interest Acknowledgments The project has been supported by grants from Science Foundation Ireland, Ireland (Starting Investigator Research Grant to ES, 09/SIRG/B1575, TIDA to ES 12/TIDA/B2388) and by the Millennium Fund of NUIG. The t(3;21)(q26;q22) is a rare cytogenetic abnorma
-
adenosine receptor antagonist In order to treat metastatic b
2019-06-20
In order to treat metastatic bone disease effectively all steps involved in the metastatic cascade need to be taken into account as for example the interactions between primary and secondary sites, tumour cell–bone cell cross talk and osteomimicri [8]. Therefore, concomitant targeting of both the tu
-
br Management of warfarin during pacemaker implantable
2019-06-20
Management of warfarin during pacemaker/implantable cardioverter defibrillator insertion Until recently, warfarin use was halted before PM/ICD insertion and the patient was bridged with intravenous (IV) unfractionated heparin or subcutaneous low-molecular-weight heparin (LMWH) if the thromboembol
-
Economic sanctions have exacerbated the brutality of this co
2019-06-20
Economic sanctions have exacerbated the brutality of this conflict many-fold, removing any prospects for peace and reconciliation. We need some reality to gauge their manifold effects before Syria descends into another Iraq, the devastating health consequences of which were well documented. Syria u
-
El otro paradigma cuyo alcance y magnitud exige atenci
2019-06-20
El otro paradigma cuyo alcance y magnitud exige atención particular es la deconstrucción y todo el giro lingüístico que la precede, un enfoque en muchos sentidos inverso Berberine Sulfate la colonialidad, aunque no en todos. Sus cauces precursores en América Latina podrían partir de figuras como Irl
-
En toda su trayectoria una constante
2019-06-20
En toda su trayectoria una constante que ha sido reconocida por la comunidad académica y por él mismo, en diversas ocasiones, fue la de “bautizar los nuevos animales”, la de crear conceptos para fenómenos nuevos que consideró específicos, en el marco de la búsqueda en su última etapa de una teoría d
-
To determine the discriminatory power
2019-06-19
To determine the discriminatory power of the ischiopubic index, the ROC curve was used (Fig. 3). The area under the curve for sex differentiation was 83.5% for the ischiopubic index. In the study MPI-0479605 with a differentiation point of 100.47°, sensitivity of 82%, specificity of 78%, and accura
-
br Methods br Results A total of cases including controls
2019-06-19
Methods Results A total of 2136 cases, including 614 controls, and 707 LAA, 375 SVO, and 440 HICH cases, were enrolled in this study. Clinical parameters between the control individuals and patients with different stroke subtypes are listed in Table 1. The average age and serum HDL-C level wer
-
br Discussion ELT is a well recognized complication of a
2019-06-19
Discussion ELT is a well-recognized complication of a dual chamber pacing system.[1,2] This is a wide QRS tachycardia resulting from the sensing of retrograde P-waves by the pacemaker, consequently triggering ventricular pacing beyond the programmed PVARP. Retrograde P-waves are induced by ectopi
-
thymidine phosphorylase inhibitor HCV does not kill the cell
2019-06-19
HCV does not kill the thymidine phosphorylase inhibitor it infects, but triggers an immune-mediated inflammatory response (hepatitis) that either rapidly clears the infection or slowly destroys the liver, causing the development of HCC and cirrhosis. The outcome is largely determined by the efficien
-
It is noteworthy that in
2019-06-19
It is noteworthy that in a recent study, Le Scouarnec et al. [199]. estimated the burden of rare coding variation in arrhythmia susceptibility genes among 167 BrS index patients and compared that with 167 individuals ≥65 years old with no history of cardiac arrhythmia. The authors concluded that, ex
-
The data obtained in our work showed
2019-06-19
The data obtained in our work showed that AMD was able to inhibit complex I activity and ATP biosynthesis in MRC-5 cells. These effects were accompanied by an increase in lipid and protein oxidative damage and a decrease in NO levels and superoxide dismutase and catalase activities, suggesting that
-
Equally in regards to the
2019-06-19
Equally, in regards to the Rt.PVs, because there was a significant difference in the direction of the myocardial activation wavefront between that during CSd and that during HRA pacing, there was a significant difference in the time it CGP 35348 took to activate the PVs (Fig. 6C, D). However, in th
16009 records 1038/1068 page Previous Next First page 上5页 10361037103810391040 下5页 Last page